Although they welcomed Finance Minister Arun Jaitley's mega healthcare proposal saying it was a step in the right direction, domestic medical devices makers said promised reforms and anticipated conducive measures to boost local manufacturing have not happened.
On the other hand, associations such as Medical Technology Association of India (MTaI) and AdvaMed said the government should not dis-incentivise technical innovation by medical device manufacturers.
"It is frustrating that against our expectations, the government has not included any measures for promoting growth of USD 10 billion Indian Medical Device market in the Budget 2018-19 as has been done for consumer electronics, food processing, footwear, etc," Association of Indian Medical Device Industry (AiMeD) Forum Coordinator Rajiv Nath said.
"Nominal tweaking in custom duty applicable to medical devices is urgently needed to address Rs 27,300 crore import bill and 70-90 per cent import dependency," Nath said.
One of the important steps the government needs to take is to increase the basic import duty on medical devices in the range of 10-15 per cent to make manufacturing more viable than importing, and give nominal protection to investors, he added.
The latter requires access to advance healthcare technology for best health management of patients. The government should have looked at incentivising import of advance medical devices into the country by bringing down the customs duty, he added.
Under the current ecosystem more than 70 per cent of medical devices have to be imported from abroad, Choudary said.
He further said a balanced approach to reduce cost to patient is trade margin rationalisation for distributors, gradation in pricing thereby allowing a higher price bracket for superior medical devices and lower customs duty.
Advanced Medical Technology Association (AdvaMed) also said: "We are truly encouraged with the Union Budget's focus on healthcare and the government's continued commitment towards achieving the long-term goal of universal health coverage".
While the Budget this year has exhibited many positives, the industry continues to urge the government of India to promote an enabling environment for the medical devices sector that is conducive to innovation, patient access and patient choice, it added.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
